Equity Compensation (Tables)
|
12 Months Ended |
Mar. 28, 2026 |
| Share-Based Payment Arrangement [Abstract] |
|
| Schedule of Activity in Total Shares Available for Grant |
The following table summarizes the activity in total shares available for grant (in thousands): | | | | | | | | Shares | | | Available for | | | Grant | | | | | | | | | | | | | | | | | | Balance, March 29, 2025 | 2,540 | | | | | Granted | (1,163) | | | Forfeited | 203 | | | Balance, March 28, 2026 | 1,580 | |
|
| Schedule of Effect of Stock-Based Compensation |
The following table summarizes the effects of stock-based compensation on cost of goods sold, research and development, sales, general and administrative, pre-tax income, and net income after taxes for shares granted under the Plan (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | Fiscal Year | | | | 2026 | | 2025 | | 2024 | | Cost of sales | | $ | 976 | | | $ | 1,332 | | | $ | 1,403 | | | Research and development | | 51,698 | | | 59,184 | | | 63,678 | | | Sales, general and administrative | | 29,137 | | | 23,630 | | | 24,190 | | | Effect on pre-tax income | | 81,811 | | | 84,146 | | | 89,271 | | | Income Tax Benefit | | (17,687) | | | (19,152) | | | (20,646) | | | Total stock-based compensation expense (net of taxes) | | 64,124 | | | 64,994 | | | 68,625 | | | Stock-based compensation effects on basic earnings per share | | $ | 1.25 | | | $ | 1.22 | | | $ | 1.26 | | | Stock-based compensation effects on diluted earnings per share | | 1.21 | | | 1.18 | | | 1.22 | |
|
| Schedule of Fair Value Assumptions for Stock Option Grants |
In fiscal years 2025 and 2024, we estimated the fair value of each stock option on the date of grant using the Black-Scholes option-pricing model using a dividend yield of zero and the following additional assumptions: | | | | | | | | | | | | | | | | | | | | | March 29, 2025 | | March 30, 2024 | | Expected stock price volatility | | | | 35.70% | | 34.53% - 39.92% | | Risk-free interest rate | | | | 4.33% | | 3.99% - 4.11% | | Expected term (in years) | | | | 3.73 | | 3.85 - 4.07 |
|
| Schedule of Stock Option Activity |
Additional information with respect to stock option activity is as follows (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | Outstanding Options | | | Number | | Weighted Average Exercise Price | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Balance, March 29, 2025 | | 504 | | | $ | 81.53 | | | | | | | | Options exercised | | (67) | | | 57.44 | | | Options forfeited | | (8) | | | 96.22 | | | | | | | | Balance, March 28, 2026 | | 429 | | | $ | 85.06 | |
|
| Schedule of Additional Information Regarding Outstanding Options that are Vesting, Expected to Vest or Exercisable |
Additional information with regards to outstanding options that are vesting, expected to vest, or exercisable as of March 28, 2026 is as follows (in thousands, except years and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Number of Options | | Weighted Average Exercise price | | Weighted Average Remaining Contractual Term (years) | | Aggregate Intrinsic Value | | Vested and expected to vest | | 426 | | | $ | 84.98 | | | 6.00 | | $ | 24,872 | | | Exercisable | | 348 | | | $ | 82.41 | | | 5.65 | | $ | 21,237 | |
|
| Schedule of Outstanding and Exercisable Options |
The following table summarizes information regarding outstanding and exercisable options as of March 28, 2026 (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Options Outstanding | | Options Exercisable | | | | | Weighted Average Remaining Contractual Life | | Weighted Average Exercise | | Number | | Weighted Average | | Range of Exercise Prices | | Number | | (years) | | Price | | Exercisable | | Exercise Price | $38.15 - $88.00 | | 228 | | | 4.77 | | $ | 73.61 | | | 226 | | | $ | 73.53 | | $93.24 - $129.24 | | 201 | | | 7.43 | | 98.07 | | | 122 | | | 98.77 | | | | 429 | | | 6.02 | | $ | 85.06 | | | 348 | | | $ | 82.41 | |
|
| Schedule of RSU Activity |
A summary of the activity for RSUs in fiscal year 2026 is presented below (in thousands, except per share amounts): | | | | | | | | | | | | | | | | | Shares | | Weighted Average Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 29, 2025 | | 2,532 | | | $ | 81.04 | | | Granted | | 710 | | | 120.61 | | | Vested | | (948) | | | 75.81 | | | Forfeited | | (126) | | | 87.16 | | | March 28, 2026 | | 2,168 | | | $ | 95.94 | |
|
| Schedule of Additional Information Regarding Outstanding RSUs Expected to Vest |
Additional information with regards to outstanding RSUs that are expected to vest as of March 28, 2026, is as follows (in thousands, except year and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | Shares | | Weighted Average Fair Value | | Weighted Average Remaining Contractual Term (years) | | Expected to vest | | 2,061 | | | $ | 95.32 | | | 1.42 |
|
| Schedule of Monte Carlo Simulation Assumptions for MSUs |
The fair values estimated from the Monte Carlo simulation were calculated using a dividend yield of zero and the following additional assumptions: | | | | | | | | | | | | | | | | | | | | | | | | Fiscal Years Ended | | | March 28, 2026 | | March 29, 2025 | | March 30, 2024 | | Expected stock price volatility | | 40.40% | | 39.34% - 41.61% | | 34.53% | | Risk-free interest rate | | 3.52% | | 3.97% - 4.15% | | 4.12% | | Expected term (in years) | | 3.00 | | 3.00 | | 3.00 |
|
| Schedule of MSU and PSU Activity |
A summary of the activity for MSUs in fiscal year 2026 is presented below (in thousands, except per share amounts):
| | | | | | | | | | | | | | | | | Shares | | Weighted Average Fair Value | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | March 29, 2025 | | 104 | | | $ | 152.23 | | | Granted | | 64 | | | 203.35 | | | Vested | | (38) | | | 128.94 | | | Forfeited | | (1) | | | 141.48 | | | March 28, 2026 | | 129 | | | $ | 182.90 | |
A summary of the activity for PSUs in fiscal year 2026 is presented below (in thousands, except per share amounts):
| | | | | | | | | | | | | | | | | Shares | | Weighted Average Fair Value | | March 29, 2025 | | 109 | | | $ | 104.41 | | | Granted | | 1 | | | 109.42 | | | Vested | | — | | | — | | | Forfeited | | (3) | | | 104.41 | | | March 28, 2026 | | 107 | | | $ | 104.48 | |
|
| Schedule of Outstanding MSUs and PSUs Expected to Vest |
Additional information with regard to outstanding MSUs that are expected to vest as of March 28, 2026 is as follows (in thousands, except year and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | Shares | | Weighted Average Fair Value | | Weighted Average Remaining Contractual Term (years) | | Expected to vest | | 119 | | | $ | 182.09 | | | 2.06 |
Additional information with regard to outstanding PSUs that are expected to vest as of March 28, 2026 is as follows (in thousands, except year and per share amounts): | | | | | | | | | | | | | | | | | | | | | | | Shares | | Weighted Average Fair Value | | Weighted Average Remaining Contractual Term (years) | | Expected to vest | | 142 | | | $ | 104.46 | | | 1.50 |
|